Hera Women's Health Highlights Sera Prognostics PRIME Trial Results Led by Brian K. Iriye, MD Showing Biomarker-Guided Care Improves Newborn Outcomes and Reduces NICU Use

"Preterm birth is one of the most impactful events we can work to prevent," said Andy Wagner, CEO, Hera Women's Health. "PRIME reinforces Hera's focus on earlier detection, standardized care pathways, and measurable outcomes—so we can reduce avoidable neonatal harm and help families start healthier." Post this Hera views preterm birth as an avoidable high-risk event in many cases: a complication that can often be anticipated earlier, managed proactively, and measured by outcomes that matter to families, he ...